Experimental tooth movement into bone induced by recombinant human bone morphogenetic protein-2
Experimental tooth movement into bone induced by recombinant human bone morphogenetic protein-2
复制标题
DOI:
10.1597/1545-1569(2003)040
复制
发表时间:
2003-09-01
期刊:
影响因子:
--
通讯作者:
Kuroda, T
中科院分区:
文献类型:
--
作者:
Kawamoto, T;Motohashi, N;Kuroda, T
Objective: The development of biomaterials for secondary bone grafting to the alveolar cleft, recombinant human morphogenetic protein-2 (rhBMP-2) may have great potential to promote osseous regeneration. The purpose of this study was to investigate the osteoinductive activity of low-dose rhBMP-2 (10 mug/100 muL) and the biological response of newly generated bone to orthodontic stimulation, compared with previous results using high-dose rhBMP-2 (40 mug/100 muL).Method. After extraction of the maxillary first premolars, bone defects were surgically created in eight adult beagle dogs using a 5-mm-diameter trepan bar. The rhBMP-2 with a PLGA/gelatin sponge complex (PGS) made of gelatin and polylactic acid polyglycolic acid copolymer was immediately implanted. The osteoinductive activity of rhBMP-2 and tooth movement into the newly generated bone was evaluated based on histological and morphometric examination.Results: Dramatic histological and morphometric differences were found in the time course of bone remodeling between low- and high-dose rhBMP-2. The onset of bone remodeling occurred significantly earlier in low-dose rhBMP-2. During experimental tooth movement, in contrast to high-dose rhBMP-2, with which root resorption occurred, only partial cementum resorption occurred on the pressure side with low-dose rhBMP-2.Conclusion: These results indicated that the proper dosage of rhBMP-2 should be determined for successful clinical application.